We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBSI icon
1451
Southside Bancshares
SBSI
$974M
$241K 0.01%
+10,820
New +$270K
SUPN icon
1452
Supernus Pharmaceuticals
SUPN
$2.77B
$241K 0.01%
+17,921
New +$277K
XL
1453
DELISTED
XL Group Ltd.
XL
$241K 0.01%
6,162
-34,713
-85% -$1.32M
CLB icon
1454
Core Laboratories
CLB
$493M
$240K 0.01%
+2,203
New +$252K
GEN icon
1455
Gen Digital
GEN
$16.6B
$240K 0.01%
11,430
-64,311
-85% -$1.31M
H icon
1456
Hyatt Hotels
H
$17.8B
$240K 0.01%
5,106
-19,647
-79% -$976K
MPWR icon
1457
Monolithic Power Systems
MPWR
$63B
$240K 0.01%
+3,756
New +$233K
NVS icon
1458
Novartis
NVS
$304B
$240K 0.01%
+3,108
New +$247K
PKX icon
1459
POSCO
PKX
$15.5B
$240K 0.01%
+6,792
New +$256K
TFC icon
1460
Truist Financial
TFC
$64.7B
$238K 0.01%
6,288
-5,414
-46% -$204K
XLF icon
1461
CALL
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
$238K 0.01%
11,391
-175,429
-94% -$3.7M
LNCE
1462
DELISTED
Snyders-Lance, Inc.
LNCE
$238K 0.01%
+6,926
New +$250K
EA icon
1463
Electronic Arts
EA
$52.4B
$237K 0.01%
3,452
-17,199
-83% -$1.21M
WRI
1464
DELISTED
Weingarten Realty Investors
WRI
$237K 0.01%
+6,851
New +$236K
MKSI icon
1465
MKS Inc
MKSI
$19.3B
$236K 0.01%
6,561
-3,507
-35% -$125K
FFIN icon
1466
First Financial Bankshares
FFIN
$5.05B
$235K 0.01%
+15,570
New +$258K
ALR
1467
DELISTED
Alere Inc
ALR
$235K 0.01%
6,014
+1,762
+41% +$75.6K
CSC
1468
DELISTED
Computer Sciences
CSC
$235K 0.01%
7,180
-19,504
-73% -$570K
GEO icon
1469
The GEO Group
GEO
$4.11B
$234K 0.01%
12,135
-4,740
-28% -$94.8K
CDK
1470
DELISTED
CDK Global, Inc.
CDK
$233K 0.01%
4,923
-17,412
-78% -$845K
ARGO
1471
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$230K 0.01%
+4,863
New +$239K
ACC
1472
DELISTED
American Campus Communities, Inc.
ACC
$230K 0.01%
+5,581
New +$220K
ACAD icon
1473
Acadia Pharmaceuticals
ACAD
$4.45B
$229K 0.01%
+6,449
New +$227K
PSO icon
1474
Pearson
PSO
$10.5B
$229K 0.01%
+21,197
New +$286K
FDS icon
1475
Factset
FDS
$10.1B
$228K 0.01%
1,401
-1,559
-53% -$262K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.